Literature DB >> 3063394

Postviral fatigue syndrome.

P O Behan1, W M Behan.   

Abstract

Myalgic Encephalomyelitis or post-viral fatigue syndrome is a common disorder, which has been known previously under a variety of different names, i.e., Iceland disease or Royal Free disease. It may occur in epidemics or sporadically. The cause is unknown, with patients complaining of exhaustion, fatigue, muscle aches and pains, and invariable psychiatric symptoms such as emotional lability, poor memory/concentration, and depression. Present-day research points to the cause as a metabolic disorder secondary to persistent viral infection.

Entities:  

Mesh:

Year:  1988        PMID: 3063394

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  26 in total

1.  Management of post-viral fatigue syndrome.

Authors:  S Wessely; A David; S Butler; T Chalder
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

2.  Conversation piece. Interview by P. D. Welsby.

Authors:  E G Dowsett
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

3.  Antidepressant therapy in the chronic fatigue syndrome.

Authors:  S Lynch; R Seth; S Montgomery
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

Review 4.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

5.  Myalgic encephalomyelitis--a persistent enteroviral infection?

Authors:  E G Dowsett; A M Ramsay; R A McCartney; E J Bell
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

6.  Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.

Authors:  A M Bakheit; P O Behan; T G Dinan; C E Gray; V O'Keane
Journal:  BMJ       Date:  1992-04-18

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

8.  Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.

Authors:  N A Miller; H A Carmichael; B D Calder; P O Behan; E J Bell; R A McCartney; F C Hall
Journal:  BMJ       Date:  1991-01-19

9.  Chronic fatigue syndrome: a follow up study.

Authors:  D Bonner; M Ron; T Chalder; S Butler; S Wessely
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

Review 10.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.